Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

Time running out for biotech

June 5, 2009 Research and Development biotech

The funding crisis which is paralysing the global biotech sector sees no sign of abating, and more and more companies …
News

Takeda delays diabetes drug in Europe

June 4, 2009 Research and Development, Sales and Marketing Takeda, diabetes

Takeda is to delay seeking European approval of its key drug candidate alogliptin, and instead take another two years to …
News

FDA to improve transparency

June 3, 2009 Research and Development FDA, US

The US medicines regulator is to boost the transparency around its decision-making, in connection with President Obama's aim to make …
News

AstraZeneca and Merck launch early stage trial collaboration

June 3, 2009 Research and Development AZ, AstraZeneca, Cancer, Merck

Merck and AstraZeneca have begun an unprecedented collaboration to bring together the clinical trials of two early stage cancer medicines.The …
News

Syntagon says China office will reduce sourcing costs

June 3, 2009 Research and Development CRO, Syntagon

News

Contract research sector: news in brief

June 2, 2009 Research and Development CRO

Pharmafocus presents a round-up of developments in the contract research sector, including a merger between etrials and Merge, new contracts …
News

INC snaps up MDS’ late-stage clinical ops

June 2, 2009 Research and Development mds

Canadian life sciences company MDS has offloaded part of its pharmaceutical services division to INC Research in a $50 million …
News

The clinical data stream: locating the headwaters

June 2, 2009 Research and Development clinical trials, data

Feature

Can European biotech stay afloat?

June 1, 2009 Research and Development biotech, economic climate, funding, investment

For the European biotech industry, the last few years have seen sustained growth across several fronts – much-needed progress after …
Feature

NICE approves Erbitux for colon cancer

June 1, 2009 Research and Development, Sales and Marketing Erbitux, NICE

NICE has approved Merck Serono's Erbitux, making it a first-line therapy for many patients with a certain type of metastatic …
News

Companies poised for swine flu vaccine drive

May 29, 2009 Research and Development, Sales and Marketing US, h1n1, vaccines

Pharmaceutical manufacturers now have access to the swine flu seed virus that can be used to start full-blown production of …
News

Sanofi adds to cancer pipeline with Exelixis deal

May 28, 2009 Research and Development, Sales and Marketing Sanofi-Aventis

Sanofi-Aventis has signed a deal with oncology-focused biotech Exelixis to co-develop two new cancer treatments.The alliance will see Sanofi gain …
News

Italian CRO Pierrel plans acquisitions

May 28, 2009 Research and Development Pierrel

Italian contract research and manufacturing company Pierrel has signed two separate deals to bolster its capabilities in the clinical research …
News

New funding for NHS research projects

May 28, 2009 Research and Development NHS

Projects ranging from diagnostics to diabetes care and genotyping have been given government funding as part of a new award …
News

Johnson & Johnson to buy Cougar Biotechnology

May 27, 2009 Research and Development, Sales and Marketing Cougar, J&J, JJ

Johnson & Johnson is to buy Los Angeles-based biotech firm Cougar Biotechnology for $970 million.The purchase, expected to go through …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026